No Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Reports Significant Decline in 2024 Preliminary Results
SHANGHAI FUDAN released its preliminary performance for the year 2024, with a net income of approximately 0.573 billion yuan, a year-on-year decrease of about 20.43%.
SHANGHAI FUDAN (01385) reported preliminary performance for the year ending December 31, 2024. The group achieved total operating revenue of approximately 3.59 billion yuan in 2024, an increase of about 1.51% compared to the previous year. The group recorded a net income attributable to the owners of the parent company of approximately 0.573 billion yuan in 2024, a decrease of about 20.43% from the previous year. The group achieved a net income attributable to the owners of the parent company, excluding non-recurring gains and losses, of approximately 0.464 billion yuan in 2024, a decrease of about 18.94% from the previous year.
Hong Kong Stock Early Report | Financial opening-up policy welcomes significant Bullish; CICC and Galaxy Securities respond to merger rumors.
① The policy for financial openness introduces significant Bullish developments, lowering the entry barrier for Financial Institutions from Hong Kong and Macau to the mainland. ② The Indonesian government has signed an investment agreement with Apple, and the sales ban on the iPhone 16 will be lifted. ③ DeepSeek has reduced the API call prices, with discounts during off-peak periods reaching up to 75%. ④ Short-selling institutions are attempting to join forces to attack the leading AI application AppLovin.
Fudan Microelectronics: 2024 Annual Results Express Announcement
2024 Annual Results Express Announcement
Selected announcements from the Hong Kong stock market | CICC and Silver Securities clarify merger rumors. SHANGHAI FUDAN's annual Net income decreased by 20% year-on-year.
① Zhongjin and Silver Securities clarified the rumors of a merger, what are the specific highlights? ② SHANGHAI FUDAN's annual Net income declined by 20% year-on-year, how is the revenue performance?
I Am 102927471 :